Table 4 Standardized incidence ratio for cancer in PLWHA by ART compliance.
From: Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea
Cancer | SIR (95% CI) | SIR Ratio (95% CI) | |
|---|---|---|---|
Optimal ART adherence | Non-optimal ART adherence | ||
Total | 1.32 (1.15, 1.51) | 2.41 (2.11, 2.75) | 0.55 (0.45, 0.66)* |
ADCs | 8.61 (6.49, 11.21) | 19.22 (15.12, 24.09) | 0.45 (0.31, 0.64)* |
Kaposi’s sarcoma | 346.11 (157.93, 657.06) | 1,121.90 (640.85, 1822.02) | 0.30 (0.12, 0.73)* |
NHL | 13.98 (9.99, 19.04) | 35.18 (26.71, 45.48) | 0.40 (0.26, 0.61)* |
Cervix | 1.71 (0.63, 3.73) | 0.45 (0.01, 2.48) | 3.84 (0.47, 176.60) |
NADCs | 0.99 (0.84, 1.16) | 1.63 (1.38, 1.92) | 0.61 (0.48, 0.77)* |
HPV-related head and neck cancer | 2.10 (0.68, 4.89) | 4.55 (1.66, 9.91) | 0.46 (0.11, 1.81) |
Stomach | 0.71 (0.40, 1.18) | 0.91 (0.45, 1.63) | 0.78 (0.34, 1.89) |
Colorectal | 0.88 (0.50, 1.43) | 1.17 (0.60, 2.04) | 0.75 (0.33, 1.74) |
Anus | 39.90 (15.98, 82.21) | 122.64 (63.30, 214.25) | 0.33 (0.11, 0.90)* |
Liver | 2.35 (1.55, 3.43) | 4.97 (3.42, 6.98) | 0.47 (0.44, 0.81)* |
Pancreas | 0.91 (0.18, 2.66) | 3.42 (1.25, 7.44) | 0.27 (0.04, 1.25) |
Lung | 1.54 (0.94, 2.38) | 2.61 (1.54, 4.12) | 0.59 (0.30, 1.19) |
Non-melanoma skin | 1.79 (0.48, 4.59) | 0.83 (0.01, 4.63) | 2.16 (0.21, 106.22) |
Breast | 0.11 (0.01, 0.38) | 0.36 (0.10, 0.91) | 0.30 (0.03, 2.09) |
Prostate | 3.18 (1.82, 5.16) | 3.63 (1.65, 6.88) | 0.88 (0.37, 2.25) |
Kidney and renal pelvis | 1.31 (0.42, 3.06) | NA (NA) | NA (NA) |
Bladder | 1.88 (0.51, 4.82) | 0.87 (0.01, 4.83) | 2.17 (0.22, 106.84) |
Thyroid | 0.24 (0.10, 0.47) | 0.23 (0.07, 0.54) | 1.03 (0.30, 4.02) |
Hodgkin’s lymphoma | 14.36 (2.89, 41.94) | 30.78 (8.28, 78.79) | 0.47 (0.07, 2.76) |
Multiple myeloma | 1.19 (0.02, 6.64) | 8.95 (2.41, 22.91) | 0.13 (0.00, 1.35) |
Leukemia | NA (NA) | 3.97 (1.28, 9.28) | 0.00 (0.00, 0.66)* |
